Company Kadimastem Ltd

Equities

KDST

IL0011284614

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE 07:24:09 2024-04-25 am EDT 5-day change 1st Jan Change
494.7 ILa +1.33% Intraday chart for Kadimastem Ltd +7.17% -16.58%

Business Summary

Kadimastem Ltd is an Israel-based regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The Company produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.

Number of employees: 12

Managers

Managers TitleAgeSince
Chief Executive Officer 54 21-01-31
Founder 85 08-10-05
Director of Finance/CFO 52 22-06-13
Chief Tech/Sci/R&D Officer - 19-12-31
Chief Tech/Sci/R&D Officer 47 08-12-31
Director/Board Member 49 20-12-16
Comptroller/Controller/Auditor 38 23-01-11
General Counsel - 20-03-31
Corporate Officer/Principal 61 09-09-14

Members of the board

Members of the board TitleAgeSince
Director/Board Member 72 20-12-16
Director/Board Member 51 22-01-02
Chairman 49 20-12-22
Founder 85 08-10-05
Director/Board Member 59 20-12-16
Director/Board Member 51 22-10-12
Director/Board Member 49 20-12-16
Director/Board Member 46 22-10-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,193,689 1,674,013 ( 39.92 %) 0 39.92 %

Company contact information

Kadimastem Ltd.

Weizmann Science Park 7 Pinchas Sapir Street

7403630, Ness Ziona

+

http://www.kadimastem.com
address Kadimastem Ltd(KDST)
  1. Stock Market
  2. Equities
  3. KDST Stock
  4. Company Kadimastem Ltd